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Background: Protruding aortic arch thrombus is associated clinically with life-threatening emboli. Definitive treatment
for aortic arch thrombus removal has demanded complicated vascular surgical procedures, with high morbidity and
mortality.
Methods and results: Transesophageal echocardiography (TEE) enabled diagnosis of a protruding thrombus at the aortic
arch in 5 patients, and a simultaneous lesion in the descending aorta in 1 patient. Four patients had visceral emboli,
coinciding with peripheral emboli in 2 patients, and the fifth patient had peripheral and cerebral emboli. One patient had
had ischemic stroke and femoral emboli a few months previously. Mean patient age was 51 years. None had clinical
evidence of coronary or peripheral atherosclerotic occlusive disease. Risk factors included hypertension (n 2), smoking
(n 4), and preexisting thrombophilia (n 4). Five patients underwent TEE-guided aortic balloon thrombectomy from
the arch with a 34-mm occluding balloon catheter. One patient also underwent balloon thrombectomy from the
descending aorta with a 14F Foley catheter. Access into the aorta was obtained through the iliac artery (n  4) during
laparotomy because of visceral ischemia or through the transfemoral approach (n  2). Previous procedures included
superior mesenteric embolectomy (n 3), segmental bowel resection (n 1), splenectomy (n 1), and peripheral arterial
embolectomy n  3). Real-time intraoperative TEE enabled visualization of the protruding thrombus and assisted with
maneuvering of the balloon catheter. At completion peripheral thrombectomy thrombus material was retrieved in 4
patients. Postoperatively there were no clinically proved new procedure-related visceral emboli, and all patients received
anticoagulant therapy thereafter. Follow-up TEE within 2 weeks and up to 7 years revealed no recurrent aortic arch
thrombus.
Conclusions:TEE-guided aortic balloon thrombectomy used in 6 procedures was effectively completed without visceral or
peripheral ischemic complications. It enabled removal of the life-threatening source of emboli from the proximal aorta,
thereby averting the need of major aortic surgery. (J Vasc Surg 2004;40:1083-8.)Protruding aortic arch thrombus is a mobile lesion that
arises from the luminal surface of the proximal aorta. It
disintegrates, and sheds arterial emboli, manifesting clini-
cally as cerebral, visceral, and peripheral ischemic events.
Aortic arch thrombus is a unique pathologic entity,1,2
readily diagnosed with transesophageal echocardiography
(TEE). However, the therapeutic approach to this lesion is
still controversial. In most cases cited in the literature,
major surgical procedures were performed to excise the
protruding thrombus. These frequently included segmen-
tal resection of the involved aortic tissue by means of
thoracotomy.1 We present a series of 5 patients with aortic
arch thrombus treated with TEE-guided aortic balloon
thrombectomy through a peripheral approach, averting the
complications of major vascular surgery.
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Five consecutive patients with aortic arch thrombus, all
with life-threatening embolic phenomena, received treat-
ment at the ShebaMedical Center, Tel Hashomer, between
1997 and 2003. Demographic data, risk factors, initial
symptoms, and method of treatment are presented in the
Table.
Medical history in one patient was noteworthy for
ischemic stroke and peripheral arterial embolic occlusion
necessitating bilateral femoral embolectomy 6 and 4
months previously, respectively. No patients in the series
had clinical evidence of coronary or peripheral chronic
arterial occlusive disease. At admission, 4 patients had
visceral ischemia, including 3 mesenteric emboli, 2 splenic
emboli, and 1 renal embolus (Fig 1,A to C). Visceral artery
embolic occlusion coincided with femoral emboli in 2
patients. In another patient peripheral embolization to the
brachial artery was followed by embolic stroke 2 days later.
One patient with splenic infarcts diagnosed at computed
tomography angiography had amiodarone-induced thyro-
toxicosis. TEE was the method used for diagnosis in all
patients, and surgery was initiated within 6 hours of diag-
nosis. In 4 patients surgical treatment was initiated with
laparotomy to address visceral ischemia, enabling splenec-
tomy (n 1), mesenteric artery embolectomy (n 3), and
segmental small bowel resection (n  1). In brief, the
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cluded exposure of the aortic bifurcation and proximal
common iliac arteries. After systemic heparinization the left
common iliac artery was clamped at its origin, and the right
common iliac artery was clamped a few centimeters beyond
its origin, followed by a transverse arteriotomy 1 cm from
the aortic bifurcation. A 0.035-inch guide wire was initially
introduced and advanced under TEE guidance into the
aortic arch. The aortic balloon catheter (34-mm venous
Stop Flow balloon catheter; Pfm, Koln, Germany) was then
introduced over the wire through this arteriotomy, and was
used in all 5 patients with aortic arch thrombus. A simulta-
neous protruding thrombus emerging off the distal de-
scending aorta in one patient was dislodged in a similar
fashion, with a 14F silicon-coated Foley catheter, without a
guide wire. Bleeding from the aorta was controlled with a
vessel loop or with manual compression of the proximal
iliac artery, which was performed throughout the process of
introduction and withdrawal of the balloon catheter. The
entire procedure lasted approximately 1 to 3 minutes, and
involved insignificant blood loss. A transfemoral approach,
used in 2 patients who did not undergo laparotomy, in-
volved surgical exposure of both common femoral arteries.
The aortic balloon catheter was introduced through a
femoral arteriotomy over the wire. As an integral part of the
aortic balloon thrombectomy real-time visualization of the
mobile mass with intraoperative TEE enabled precise posi-
tioning of the catheter proximal to the thrombus, inflation
of the balloon to the appropriate diameter, and validation
of total dislodgement of the aortic arch thrombus, which
signaled for the deflation of the balloon.
Thrombusmaterial relocalized at the aortic bifurcation,
and was conveniently retrieved at completion thrombec-
tomy with a No. 5 Fogarty embolectomy catheter. The
Demographic data, risk factors, site of aortic arch thrombu
Patient
No. Sex
Age
(y) Ischemic heart disease/
1 F 50 -
2 M 62 -
3 F 52 -
4 F 46 -
5 F 45 Rheumatic heart diseas
mitral valve stenosis, m
valve regurgitation, rap
atrial fibrillation, left at
thrombusright common iliac approach provided direct access to thethrombus at the bifurcation, whereas the transfemoral ap-
proach necessitated bilateral femoral embolectomy.
Aortic balloon thrombectomy was performed in all
patients after they provided detailed informed consent,
which also noted the “off label” use of the aortic balloon
catheter and the Foley catheter.
All patients received full-dose heparin therapy during
and immediately after the procedure, followed by long-
term warfarin sodium (Coumadin) therapy. Statin drugs
were also given to all patients postoperatively. Follow-up
TEE was performed after 2 weeks, at 3 months, and annu-
ally for up to 7 years (2 patients).
RESULTS
In all patients TEE demonstrated a grade II3 2 to 3-mm
shallow aortic plaque at the site of anchorage for the
stalked, mobile 1.5 to 2.3-cm polyp-like lesion. The lesion
was located at the distal arch in 4 patients (isthmus), and in
the mid-arch, facing the left common carotid artery orifice,
in 1 patient. A simultaneous lesion at the distal descending
aorta was found in 1 patient. Except for the localized
shallow atherosclerotic lesion, no other plaques were visu-
alized with TEE in the proximal aorta in any patients.
TEE-guided balloon thrombectomy from the aortic
arch was performed in 5 patients, and from the descending
aorta in 1 patient (Fig 2). The procedure was effective in all
patients. The mobile thrombus, as the source of emboli,
was dislodged from its anchorage in the aortic wall, leaving
a negligible thrombus remnant. The dislodged mass was
instantly delivered for retrieval with peripheral completion
Fogarty thrombectomy. It should be noted that although
no endovascular precautions were exercised to prevent
accidental visceral embolization during aortic thrombus
dislodgement, no such event was clinically recorded (data
nical findings, and therapeutic approach
ptomatic cardiac disease and risk factors
Hypertension
Diabetes
mellitus Dyslipidemia
 - -
- - -
 - -
- - -
 - -s, cli
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e,
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rialconfirmed later at computed tomography angiography).
phy; M
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ever, in 2 procedures transfemoral completion thrombec-
tomy failed to retrieve any thrombus, suggesting that this
material may have relocated within the internal iliac arter-
ies. Histopathologic examination of the retrieved material
revealed organized thrombus devoid of any atheromatous
material in all analyses (Fig 1, D). All patients underwent
full workup of the coagulation system, which revealed
preexisting thrombophilia in 4 patients, including activated
protein C resistance (heterozygous) in 1 patient, factor II
mutation (heterozygous) in 1 patient, and hyperhomocys-
teinemia (5,10-methylene tetrahydrofolate reductase, ho-
mozygous) in 2 patients. The fifth patient, who had a
stormy course of amiodarone-induced thyrotoxicosis, ex-
hibited an inflammatory state, another suggested pro-
thrombotic tendency.
There were no further embolic events in the immediate
postoperative period or throughout follow-up. Periodic
TEE assessments for up to 7 years revealed irregularity of
the luminal surface at the site of the treated protruding
thrombus. However, there was no recurrence of protrud-
ing thrombosis at the aortic arch or at any other site in the
proximal aorta. During follow-up 2 patients died, of sepsis
related to total thyroidectomy 6 weeks later and metastatic
breast carcinoma 2 years postoperatively.
DISCUSSION
The pathogenesis of protruding aortic arch thrombus is
obscure. Assumed analogous arterial conditions such as
acute coronary syndrome4-6or cerebrovascular ischemia7 as
related to symptomatic carotid plaque, demonstrate the
association between atherosclerosis and local thrombosis.
Therefore, it is suggested that aortic arch thrombus is
another manifestation of the same pathologic entity, and
(Continued)
Symptomatic cardiac disease and risk factors
Site of protruding
thrombusSmoking
Thrombophilia/ prothrombotic
state
 APCR, heterozygous A. Distal descending
B. Distal arch
 Factor II mutation, heterozygous Distal arch
 Hyperhomo-cysteinemia;
MTHFR, homozygous
Distal arch
 Breast cancer; chemotherapy;
hyperhomo-cysteinemia;
MTHFR, homozygous
Mid-arch
- Amiadarone-induced
thyrotoxicosis
Distal arch
APCR, Activated protein C resistance; TEE, transesophageal echocardiograacute rupture or fissuring of a shallow aortic (lipid-rich)vulnerable plaque may initiate the process, with subsequent
instant local thrombosis.8 Among risk factors for acute
arterial syndromes at the coronary, carotid, or aortic arter-
ies, systemic inflammation, as elicited by smoking,9 and
prothrombotic states, such as preexisting thrombophilia,
seem to have a key role. The presence of these systemic
factors may further support the current concept of the
“vulnerable patient”10 prone to plaque rupture. In our
series, most patients (4 of 5) were heavy cigarette smokers,
and 1 patient sustained amiodarone-induced thyrotoxico-
sis. In addition, preexisting thrombophilia was diagnosed
in 4 patients. It is noteworthy that thrombophilias such as
activated protein C resistance (heterozygous) and factor II
mutation (heterozygous) have been considered in the past
as risk factors for venous thrombogenesis.11-13 However,
combined with the assumed plaque rupture in our patients,
these thrombophilias may have contributed to arterial
thrombosis.
Within 7 years of follow-up (1997-2003) the preva-
lence of arterial emboli directly related to aortic arch pro-
truding thrombus in our institution has been approxi-
mately 3% of the total number of spontaneous visceral and
peripheral arterial emboli. This is an unexpectedly high
percentage, and suggests that aortic arch protruding
thrombus may be a significant source of emboli, in light of
gradually decreasing rates of emboli of cardiac origin.
All patients in our series had life-threatening emboli,
mainly affecting the splanchnic arteries. These critical circum-
stanceswarrant early diagnosis and treatment, including rever-
sal of ischemia and removal of the source of emboli.However,
diagnosis of aortic arch thrombus was delayed in 2 patients,
because TEEwas not part of the diagnostic protocol. Further-
more, once performed, TEE enabled accurate diagnosis and
directly assisted in definitive treatment. Our data advocate
Clinical findings Treatment
senteric ischemia, spleenic
nd renal infarcts, bilateral
moral artery occlusion
Splenectomy, mesenteric and bilateral
femoral endarterectomy; A and B,
TEE-guided aortic balloon
thrombectomy
senteric ischemia Mesenteric endarterectomy, small
bowel segment resection, TEE-
guided aortic balloon
thrombectomy
c and bilateral femoral
mboli, mesenteric
chemia
Iliac and bilateral femoral
embolectomy, mesenteric
embolectomy, TEE-guided aortic
balloon thrombectomy
t brachial occlusion, left
emispheric ischemic
troke
Brachial embolectomy, TEE-guided
aortic balloon thrombectomy
nic infarcts TEE-guided aortic balloon
thrombectomy
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Spleexpanded use of TEE to all cases of arterial emboli of unclear
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visceral emboli.14
From case reports and our own experience, it is clear
that the source of emboli should be approached surgically
and without undue delay. Among the methods attempted
for treatment of aortic arch thrombus, systemic hepariniza-
tion was partially effective in preventing further emboli in a
large series of 23 patients.2 In another series of 9 patients
intravenously administered heparin may have contributed
to resolution of aortic arch thrombus in 4 patients.15 How-
ever, in both series surgery was necessary inmost patients to
remove the source of emboli. Fibrinolysis with rt-PA was
utilized successfully in one reported case.16 However, in
our view, this modality may disolve the thin stalk of anchor-
age, and bring about uncontrolled dislodement of the
thrombus mass. Endovascular stent grafting has recently
been used to contain a recurrent aortic protruding throm-
bus.17 The treatment of choice in most cited clinical series
involved surgical excision of the affected aortic wall seg-
ment via aortotomy, with major cardiovascular surgical
Fig 1. Clinical findings in patient 1. A, Proximal aorto
surface of the aorta.B,Abdominal computed tomograph
C, Selective superior mesenteric arteriogram demonstra
origin (arrowhead).D,Histologic analysis of retrieved pr
thrombus with multiple fibroblasts (arrowheads); Hem
thrombus is devoid of any atheromatous material.procedures15,18 associated with significant morbidity andmortality. In contrast, our surgical approach is minimally
invasive, with limited surgical trauma. It involves visually
controlled dislodgement of the aortic thrombus from the
arch, followed by peripheral completion thrombectomy.
Moreover, the aortic balloon thrombectomy was per-
formed in most instances sequentially with surgical proce-
dures to treat embolic occlusion of splanchnic and periph-
eral arteries. It should be noted that no further visceral
emboli attributable to dislodgement of the protruding
thrombus were recorded. This may be explained in part by
the observation that the mobile thrombus is disconnected
from its stalk as a single sizeablemass (as visualized at TEE),
thereby reducing the likelihood of new emboli in smaller
visceral arteries.
Our limited experience in treating 6 cases of aortic arch
protruding thrombus suggests that the abdominal ap-
proach may be preferable to the transfemoral approach for
the following reasons. It allows initial assessment of the
visceral vasculature, and subsequently its reevaluation im-
mediately after aortic thrombectomy, thereby addressing
demonstrates normal looking, regular, smooth luminal
demonstrates total infarction of the spleen (arrowhead).
bolic occlusion of the vessel a few centimeters from its
ing thrombus revealed a typical appearance of organized
lin and eosin; original magnification 400. Note thatgram
y scan
tes em
otrud
atoxythe critical issue of potential embolization into visceral
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into the internal iliac arteries. It also provides better control
and maneuverability of the guide wire and balloon catheter
when introduced directly through the aortic bifurcation.
In summary, our limited experience in 5 patients, pre-
senting 6 cases of symptomatic aortic protruding thrombus
suggests that TEE-guided aortic balloon thrombectomy
combined with completion peripheral thrombectomy may
be effective in removing the source of life-threatening
emboli. The safety of this procedure warrants thorough
investigation in a larger series of patients before it can be
generally adopted by the vascular community as a first-line
therapy for aortic arch protruding thrombi.
Furthermore, prevention of aortic arch thrombus re-
currence after successful treatment with balloon thrombec-
tomy warrants life-long anticoagulation therapy to attenu-
ate prothrombotic tendencies. In our view, although
speculative, extrapolating from coronary and carotid ath-
erosclerotic disease, it seems intuitively appropriate to ad-
minister statin drugs postoperatively in patients with aortic
arch thrombus. This therapy may contribute to pacification
of the aortic arch thrombus plaque of origin, as well as other
Fig 2. A, Intraoperative transesophageal echocardiogr
view, with a pedunculated protruding thrombus (Th). B
is introduced beyond thrombus. C, Balloon inflation
(arrowhead).potentially vulnerable aortic plaques.REFERENCES
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